K2 Principal Fund, L.P. Pacific Biosciences Of California, Inc. Transaction History

K2 Principal Fund, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$2.36 - $5.26 $36,108 - $80,478	-15,300 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$4.6 - $5.57 $70,380 - $85,221	15,300 New	15,300 $79,000
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.41 $957,246 - $1.2 Million	-161,697 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$6.8 - $7.4 $1.1 Million - $1.2 Million	161,697 New	161,697 $1.17 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $443M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.